PXS Cleared to Progress to Phase 2 Bone Marrow Cancer Trial
04/10/2021 22:34
Australia Stock Exchange release from PHARMAXIS LTD PXS.AX : PXS Cleared to Progress to Phase 2 Bone Marrow Cancer Trial
- AU$37.28m
- AU$23.71m
- AU$6.84m
Australia Stock Exchange release from PHARMAXIS LTD PXS.AX : PXS Cleared to Progress to Phase 2 Bone Marrow Cancer Trial